Sandbox 77: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 15: Line 15:


== References ==
== References ==
{{cite journal |last=Berumen |first=Laura Cristina |last2=Rodriguez |first2=Angelina |last3=Miledi |first3=Ricardo |last4=Garcia-Alcocer |first4=Guadalupe |date= 2 May 2015 |title= [Serotonin Receptors in Hippocampus.] |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353568 |journal=The Scientific World Journal |publisher=The Scientific World Journal |volume= |issue= |pages= |doi= |access-date=15 November 2015}}


{{cite journal |last=Goodsell |first=David |date=Aug 2013 |title=”Serotonin Receptor.” |url=http://www.rcsb.org/pdb/101/motm.do?momID=164|access-date= 2015}}
1. {{journal |last=Berumen |first=Laura Cristina |last2=Rodriguez |first2=Angelina |last3=Miledi |first3=Ricardo |last4=Garcia-Alcocer |first4=Guadalupe |date= 2 May 2015 |title= [''Serotonin Receptors in Hippocampus''.] |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353568 |journal=The Scientific World Journal |publisher=The Scientific World Journal |volume= |issue= |pages= |doi= |access-date=15 November 2015}}


{{cite journal |last=Wiebke |first=Janssen |last2=Schymura |first2=Yves |last3=Novoyatleva |first3=Tatyana |last4=Kojonazarov |first4=Baktybek |last5=Boehm |first5=Mario |last6=Wietelmann |first6=Astrid |last7=Luitel |first7=Himal |last8=Murmann |first8=Kristen |last9=Krompiec |first9=Damian Richard |last10=Tretyn |first10=Aleksandra |last11=Pullamsetti |first 11=Soni Savi |last12=Weissmann |first12=Norbert |last13=Seeger |first13=Werner |last14=Ghofrani |first14=Hossein Ardeschir |last15=Schermuly |first15=Ralph Theo |date=1 February 2015 |title=”5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312574 |journal=BioMed Research International |publisher=Hindawi Publishing corporation |access-date=15 November 2015}}
2. {{journal |last=Goodsell |first=David |date=Aug 2013 |title=”Serotonin Receptor.” |url=http://www.rcsb.org/pdb/101/motm.do?momID=164|access-date= 2015}}


{{cite web |last=Nebigil |last2=Etienne |last3=Schaerlinger |last4=Hickel |last5=Launay |last6=Maroteaux |date=22 May 2001 |title=Developmentally Regulated Serotonin 5-HT2B Receptors.” |url=http://www.sciencedirect.com/science/article/pii/S0736574801000223 publisher=Sciencedirect |access-date=15 November 2015}}
3. {{journal |last=Wiebke |first=Janssen |last2=Schymura |first2=Yves |last3=Novoyatleva |first3=Tatyana |last4=Kojonazarov |first4=Baktybek |last5=Boehm |first5=Mario |last6=Wietelmann |first6=Astrid |last7=Luitel |first7=Himal |last8=Murmann |first8=Kristen |last9=Krompiec |first9=Damian Richard |last10=Tretyn |first10=Aleksandra |last11=Pullamsetti |first 11=Soni Savi |last12=Weissmann |first12=Norbert |last13=Seeger |first13=Werner |last14=Ghofrani |first14=Hossein Ardeschir |last15=Schermuly |first15=Ralph Theo |date=1 February 2015 |title=”5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312574 |journal=BioMed Research International |publisher=Hindawi Publishing corporation |access-date=15 November 2015}}


{{cite web |last=Thompson |first=A. J. |last2=Lummis |first2=S. C. R. |date=2 April 2009 |title=”%-HT3 Receptors.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664614/ |journal=Current Pharmaceutical Design |publisher=U.S. National Library of Medicine |access-date=15 November 2015}}
4. {{journal |last=Nebigil |last2=Etienne |last3=Schaerlinger |last4=Hickel |last5=Launay |last6=Maroteaux |date=22 May 2001 |title=Developmentally Regulated Serotonin 5-HT2B Receptors.” |url=http://www.sciencedirect.com/science/article/pii/S0736574801000223 publisher=Sciencedirect |access-date=15 November 2015}}


{{cite journal |last=Wang |last2=Chong |last3=Jiang |first3=Yi |last4= Ma |first4=Jinming |last5=Wu |first5=Huixian |last6=Wacker |first6=Daniel |last7=Katritch |first7=Vsevolod |last8=Han |first8=Gye Won |last9=Liu |first9=Wei |last10=Huang |first10Xi-Ping |last11=Vardy |first11=Eval |last12=McCorvy |first12=John D. |last13=Gao |first13=Xiang |last14=Zhou |first14=Edward X. Zhou |last15=Melcher |first15=Karsten |last16=Zhang |first16=Chenghai |last17=Bai |first17=Fang |last18=Yang |first18=Huaiyu |last19=Yang |first19=Linlin |last20=Jiang |first20=Hualiang |last21=Roth |first21=Bryan L. |last22=Cherezov |first22=Vadim |last23=Stevens |first23=Raymond C. |last24=Xu |first24=H. Eric |date=21 March 2013 |title=”Structural Basis for Molecular Recognition at Serotonin Receptors.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644373/ |journal=Science |publisher=U.S. National Library of Medicine |access-date=15 November 2015}}
5. {{journal |last=Thompson |first=A. J. |last2=Lummis |first2=S. C. R. |date=2 April 2009 |title=”%-HT3 Receptors.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664614/ |journal=Current Pharmaceutical Design |publisher=U.S. National Library of Medicine |access-date=15 November 2015}}
 
6. {{journal |last=Wang |last2=Chong |last3=Jiang |first3=Yi |last4= Ma |first4=Jinming |last5=Wu |first5=Huixian |last6=Wacker |first6=Daniel |last7=Katritch |first7=Vsevolod |last8=Han |first8=Gye Won |last9=Liu |first9=Wei |last10=Huang |first10Xi-Ping |last11=Vardy |first11=Eval |last12=McCorvy |first12=John D. |last13=Gao |first13=Xiang |last14=Zhou |first14=Edward X. Zhou |last15=Melcher |first15=Karsten |last16=Zhang |first16=Chenghai |last17=Bai |first17=Fang |last18=Yang |first18=Huaiyu |last19=Yang |first19=Linlin |last20=Jiang |first20=Hualiang |last21=Roth |first21=Bryan L. |last22=Cherezov |first22=Vadim |last23=Stevens |first23=Raymond C. |last24=Xu |first24=H. Eric |date=21 March 2013 |title=”Structural Basis for Molecular Recognition at Serotonin Receptors.” |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644373/ |journal=Science |publisher=U.S. National Library of Medicine |access-date=15 November 2015}}